IFNG and breast carcinoma: Undoubtedly, the mechanisms governing tumor cell expression of HLA-II in breast carcinoma are likely multifaceted, involving IFN-γ secreted by infiltrating immune cells [12], circulating and tumor-associated estrogens [41] and activation of growth factor and hormone receptor pathways in the tumor cells [42], [43].